Clemedi
Clemedi is a Swiss company based in Zurich that develops diagnostics for infectious diseases by combining DNA sequencing and smart software. Their mission is to give the right antibiotics by providing faster, comprehensive diagnostic tests that support targeted therapy, thereby helping to limit antimicrobial resistance. They offer products such as Tuberculini, a diagnostic test for drug-resistant tuberculosis, and are expanding into other infectious diseases including latent tuberculosis, sexually transmitted infections, and hospital-acquired infections. The company is actively involved in product development, market entry, and strategic partnerships, with a focus on improving infectious disease diagnostics through innovative sequencing and bioinformatics technologies.
Industries
Nr. of Employees
small (1-50)
Products
Sequencing-based tuberculosis diagnostic kit (CE‑IVD)
A targeted sequencing workflow and accompanying software for species identification, genotyping/lineage determination, and detection of resistance-associated mutations for a panel of tuberculosis antibiotics directly from patient samples (e.g., sputum) with results reported within ~48 hours. CE‑IVD certified for the EU market.
Sequencing-based tuberculosis diagnostic kit (CE‑IVD)
A targeted sequencing workflow and accompanying software for species identification, genotyping/lineage determination, and detection of resistance-associated mutations for a panel of tuberculosis antibiotics directly from patient samples (e.g., sputum) with results reported within ~48 hours. CE‑IVD certified for the EU market.
Services
Supply of sequencing-based diagnostic reagent kits
Provision of reagent kits for targeted sequencing workflows to detect pathogens and resistance markers from clinical samples.
Diagnostic data analysis software (local or offline deployment)
Software to analyze sequencing data and produce species identification and drug-susceptibility reports; available as standalone local install or web-hosted interface.
OEM / white-label and distribution partnerships
Commercial agreements to supply components or sell kits under partner branding and to establish distribution channels in target geographies.
Clinical evaluation and evidence generation support
Collaboration with clinical laboratories and research partners to perform evaluations, generate analytical/clinical performance data, and support manuscript publication.
Supply of sequencing-based diagnostic reagent kits
Provision of reagent kits for targeted sequencing workflows to detect pathogens and resistance markers from clinical samples.
Diagnostic data analysis software (local or offline deployment)
Software to analyze sequencing data and produce species identification and drug-susceptibility reports; available as standalone local install or web-hosted interface.
OEM / white-label and distribution partnerships
Commercial agreements to supply components or sell kits under partner branding and to establish distribution channels in target geographies.
Clinical evaluation and evidence generation support
Collaboration with clinical laboratories and research partners to perform evaluations, generate analytical/clinical performance data, and support manuscript publication.
Expertise Areas
- Sequencing-based infectious disease diagnostics
- Antimicrobial resistance detection and interpretation
- Bioinformatics and machine-learning for diagnostics
- Assay development and analytical validation
Key Technologies
- Next-generation sequencing (amplicon/targeted sequencing)
- Highly multiplex PCR
- Pathogen DNA extraction from sputum and blood
- Machine learning for antibiotic susceptibility prediction